(Q36477169)

14 August 2017

The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer (English)

1 reference

14 August 2017

1 reference

Michael F Verderame

3

0 references

author name string

Fan Cheng

series ordinal

1

1 reference

14 August 2017

Patricia J McLaughlin

series ordinal

2

1 reference

14 August 2017

Ian S Zagon

series ordinal

4

1 reference

14 August 2017

11 January 2008

1 reference

14 August 2017

1 reference

14 August 2017

7

1 reference

14 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1186/1476-4598-7-5

14 August 2017

0 references

cites work

The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Progression elevated gene-3 promoter (PEG-Prom) confers cancer cell selectivity to human polynucleotide phosphorylase (hPNPase(old-35))-mediated growth suppression.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Opioids and differentiation in human cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

The genetics of pancreatic cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Opioids and the apoptotic pathway in human cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Methods used for the study of opioid receptors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirus.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Characterization of a new primary human pancreatic tumor line.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Morphological, biological, biochemical, and karyotypic characteristics of human pancreatic ductal adenocarcinoma Capan-2 in tissue culture and the nude mouse

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Establishment of a continuous tumor-cell line (PANC-1) from a human carcinoma of the exocrine pancreas

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Treatment of advanced pancreatic cancer with opioid growth factor: phase I.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Opioid growth factor regulates the cell cycle of human neoplasias

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

Opioid growth factor inhibits DNA synthesis in mouse tongue epithelium in a circadian rhythm-dependent manner

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2253554

The biology of the opioid growth factor receptor (OGFr)

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1476-4598-7-5

DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1476-4598-7-5

Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18190706

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18190706

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18190706

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1476-4598-7-5

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

1 reference